13.4% dip in daily COVID-19 cases, 11.7% drop in active cases in a day

The COVID-19 trajectory in all the states and UTs in India continues on a downward curve with a rapid fall in fresh infections and active cases

Sumi Sukanya Dutta

February 11, 2022 / 09:55 IST

India has recorded 58,077 COVID-19 cases in the last 24 hours, down from 67,084 daily cases a day before. This marks a 13.4 percent decline in the fresh infections in a day.

The fresh number of confirmed COVID-19 infection take the tally of confirmed cases in the country to 4,25,36, 137.

With 657 deaths registered in a day, the death toll due to the infectious disease has now reached 5,07, 177 while the COVID-19 mortality rate nationally stands at 1.2 percent.

Of these, 153 were the backlog deaths from Kerala which, at 188, also reported the highest COVID-19 fatalities in day. The second highest deaths, 45, were reported from Maharashtra while Karnataka reported 39 deaths in a day.

A look at countries that are easing international travel rules

The number of active cases in the country now stands at 6,97, 802, down from 7,90,789 cases a day before. In percentage terms, it means a fall of 11.7 percent within the 24-hour period. Kerala which has the highest number of active COVID-19 cases in the country—2,33, 747, also reported the biggest dip of 25,207 in this figure.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show